Clinical trial
A Prospective, Randomized, Controlled, Multi-Center Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation
NCT05945329 is registered in ClinicalTrials.gov with C. R. Bard as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Randomized, Controlled, Multi-Center Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation
- Lead sponsor
- C. R. Bard
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- December 12, 2024
- Completion date
- February 28, 2029
- Enrollment
- 250 (estimated)
- Sites
- 37
Conditions
As the registry lists them; a condition with its own page is linked.
capsular contracture associated with breast implant, capsular contracture grade iii, capsular contracture grade iv